175 related articles for article (PubMed ID: 30531722)
1. In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening.
Crespo R; Koudstaal W; Apetri A
J Vis Exp; 2018 Nov; (141):. PubMed ID: 30531722
[TBL] [Abstract][Full Text] [Related]
2. Zinc Binding to Tau Influences Aggregation Kinetics and Oligomer Distribution.
Moreira GG; Cristóvão JS; Torres VM; Carapeto AP; Rodrigues MS; Landrieu I; Cordeiro C; Gomes CM
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31783644
[TBL] [Abstract][Full Text] [Related]
3. Melatonin interacts with repeat domain of Tau to mediate disaggregation of paired helical filaments.
Balmik AA; Das R; Dangi A; Gorantla NV; Marelli UK; Chinnathambi S
Biochim Biophys Acta Gen Subj; 2020 Mar; 1864(3):129467. PubMed ID: 31715192
[TBL] [Abstract][Full Text] [Related]
4. Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments.
Barghorn S; Mandelkow E
Biochemistry; 2002 Dec; 41(50):14885-96. PubMed ID: 12475237
[TBL] [Abstract][Full Text] [Related]
5. Tau filaments in neurodegenerative diseases.
Goedert M
FEBS Lett; 2018 Jul; 592(14):2383-2391. PubMed ID: 29790176
[TBL] [Abstract][Full Text] [Related]
6. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans.
Goedert M; Jakes R; Spillantini MG; Hasegawa M; Smith MJ; Crowther RA
Nature; 1996 Oct; 383(6600):550-3. PubMed ID: 8849730
[TBL] [Abstract][Full Text] [Related]
7. Aggregation Kinetics and Filament Structure of a Tau Fragment Are Influenced by the Sulfation Pattern of the Cofactor Heparin.
Townsend D; Fullwood NJ; Yates EA; Middleton DA
Biochemistry; 2020 Oct; 59(41):4003-4014. PubMed ID: 32954725
[TBL] [Abstract][Full Text] [Related]
8. The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments.
Jeganathan S; von Bergen M; Mandelkow EM; Mandelkow E
Biochemistry; 2008 Oct; 47(40):10526-39. PubMed ID: 18783251
[TBL] [Abstract][Full Text] [Related]
9. Major Differences between the Self-Assembly and Seeding Behavior of Heparin-Induced and in Vitro Phosphorylated Tau and Their Modulation by Potential Inhibitors.
Despres C; Di J; Cantrelle FX; Li Z; Huvent I; Chambraud B; Zhao J; Chen J; Chen S; Lippens G; Zhang F; Linhardt R; Wang C; Klärner FG; Schrader T; Landrieu I; Bitan G; Smet-Nocca C
ACS Chem Biol; 2019 Jun; 14(6):1363-1379. PubMed ID: 31046227
[TBL] [Abstract][Full Text] [Related]
10. Screening for inhibitors of tau polymerization.
Pickhardt M; von Bergen M; Gazova Z; Hascher A; Biernat J; Mandelkow EM; Mandelkow E
Curr Alzheimer Res; 2005 Apr; 2(2):219-26. PubMed ID: 15974921
[TBL] [Abstract][Full Text] [Related]
11. Detection and Quantification Methods for Fibrillar Products of In Vitro Tau Aggregation Assays.
Nanavaty N; Lin L; Hinckley SH; Kuret J
Methods Mol Biol; 2017; 1523():101-111. PubMed ID: 27975246
[TBL] [Abstract][Full Text] [Related]
12. Chaperoning activity of the cyclophilin family prevents tau aggregation.
Hill SE; Esquivel AR; Ospina SR; Rahal LM; Dickey CA; Blair LJ
Protein Sci; 2022 Nov; 31(11):e4448. PubMed ID: 36305768
[TBL] [Abstract][Full Text] [Related]
13. The FK506-binding protein FKBP52 in vitro induces aggregation of truncated Tau forms with prion-like behavior.
Giustiniani J; Guillemeau K; Dounane O; Sardin E; Huvent I; Schmitt A; Hamdane M; Buée L; Landrieu I; Lippens G; Baulieu EE; Chambraud B
FASEB J; 2015 Aug; 29(8):3171-81. PubMed ID: 25888602
[TBL] [Abstract][Full Text] [Related]
14. Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.
Guo JL; Narasimhan S; Changolkar L; He Z; Stieber A; Zhang B; Gathagan RJ; Iba M; McBride JD; Trojanowski JQ; Lee VM
J Exp Med; 2016 Nov; 213(12):2635-2654. PubMed ID: 27810929
[TBL] [Abstract][Full Text] [Related]
15. Tau aggregation followed by atomic force microscopy and surface plasmon resonance, and single molecule tau-tau interaction probed by atomic force spectroscopy.
Barrantes A; Sotres J; Hernando-Pérez M; Benítez MJ; de Pablo PJ; Baró AM; Avila J; Jiménez JS
J Alzheimers Dis; 2009; 18(1):141-51. PubMed ID: 19625749
[TBL] [Abstract][Full Text] [Related]
16. Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells.
Pickhardt M; Larbig G; Khlistunova I; Coksezen A; Meyer B; Mandelkow EM; Schmidt B; Mandelkow E
Biochemistry; 2007 Sep; 46(35):10016-23. PubMed ID: 17685560
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of the binding of thioflavin S to tau paired helical filaments.
Santa-María I; Pérez M; Hernández F; Avila J; Moreno FJ
J Alzheimers Dis; 2006 Aug; 9(3):279-85. PubMed ID: 16914838
[TBL] [Abstract][Full Text] [Related]
18. Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition.
Cox K; Combs B; Abdelmesih B; Morfini G; Brady ST; Kanaan NM
Neurobiol Aging; 2016 Nov; 47():113-126. PubMed ID: 27574109
[TBL] [Abstract][Full Text] [Related]
19. Structural impact of heparin binding to full-length Tau as studied by NMR spectroscopy.
Sibille N; Sillen A; Leroy A; Wieruszeski JM; Mulloy B; Landrieu I; Lippens G
Biochemistry; 2006 Oct; 45(41):12560-72. PubMed ID: 17029411
[TBL] [Abstract][Full Text] [Related]
20. Tau phosphorylation and aggregation in Alzheimer's disease pathology.
Avila J
FEBS Lett; 2006 May; 580(12):2922-7. PubMed ID: 16529745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
